Refex Industries Limited Submission of Monitoring Agency Reports for Q4 FY2026

Refex Industries Limited has published its Monitoring Agency Reports for the quarter ended March 31, 2026. These reports provide an objective view of the utilization of proceeds from its recent preferential issues of equity shares and warrants. The company confirmed that funds are being deployed effectively, with no major deviations observed in the project objects. This disclosure ensures transparency regarding capital allocation for its working capital and corporate development initiatives.

Preferential Issue Progress

The company has undergone detailed monitoring for two distinct preferential issue events. The first, initiated via an EGM notice dated March 27, 2024, involved an issue size of ₹220 crore. The second, initiated via an EGM notice dated October 26, 2024, had an issue size of ₹905.44 crore. Both reports confirm that the utilization of funds is consistent with the stated objects in the respective offer documents.

Utilization and Project Status

As of March 31, 2026, the monitoring reports highlight the following status for the utilization of funds:

  • Working Capital: Significant portions of funds have been allocated to meet ongoing operational requirements, with projects continuing as planned.
  • Capital Expenditure: Deployment is progressing in line with expectations, supporting the company’s infrastructure and asset expansion goals.
  • Investment in Subsidiaries: Strategic investments have been completed, contributing to the broader corporate development plan.

Compliance and Market Context

The reports include important disclosures regarding warrant conversions. Specifically, the company noted that for the October 2024 preferential issue, certain outstanding warrants lapsed after the May 06, 2026 exercise deadline. Consequently, the upfront subscription amount representing 25% of the warrant issue price has been forfeited in accordance with regulatory requirements. Despite minor adjustments in total issue size due to under-subscription, the company’s core operational objectives remain on track.

Source: BSE

Previous Article

Zydus Lifesciences Independent Director Apurva S. Diwanji Steps Down

Next Article

Schneider Electric Infrastructure Limited Update on Registrar and Share Transfer Agent Merger